Biotechnology Top Losers - Geron Corporation, Curis, ImmunoCellular ...

11-11-2013 eFinance HubComments (0)


Geron Corporation (NASDAQ:GERN) has reported financial results for the third quarter ended on September 30, 2013. For 3Q of 2013, company also reported a net loss of $8.3 million, or $0.06 per share, as compared to $16.0 million, or $0.13 per share, ...

Read more on eFinance Hub

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top